Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1986 May;58(2):331-8.
doi: 10.1128/JVI.58.2.331-338.1986.

Regulation of herpes simplex virus-specific cell-mediated immunity by a specific suppressor factor

Regulation of herpes simplex virus-specific cell-mediated immunity by a specific suppressor factor

D W Horohov et al. J Virol. 1986 May.

Abstract

Our study was designed to investigate the nature of an antigen-specific suppressor factor generated by antigen-stimulated herpes simplex virus (HSV)-immune splenocytes. Factor SF-200, a 90,000- to 100,000-dalton fraction obtained after Sephacryl gel filtration, suppressed the generation of HSV-specific cytotoxic T-lymphocyte and lymphoproliferative responses. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis and Western blot analysis of SF-200 indicated that it contained an I-J+, anti-idiotypic protein. It was possible to adsorb the suppressor activity of SF-200 to an anti-I-J immunoaffinity column. The suppressor activity could be eluted from the immunoaffinity column with a low-pH buffer. The acid-eluted material was determined to be both I-J+ and reactive with anti-HSV antiserum by Western blot analysis. Both SF-200 and the I-J+ suppressor activity suppressed only HSV-specific cell-mediated immunity responses. However, it was possible to generate nonspecific suppressor activity by incubating the I-J+ suppressor factor with Lyt 1+ splenocytes from HSV-immune mice. The implication of these results with respect to the model for a suppressor cell circuit regulating HSV-specific cell-mediated immunity responses is discussed.

PubMed Disclaimer

References

    1. Diagn Immunol. 1983;1(3):245-56 - PubMed
    1. J Virol. 1984 Nov;52(2):630-7 - PubMed
    1. J Virol. 1985 Jun;54(3):798-803 - PubMed
    1. J Virol. 1985 Oct;56(1):1-6 - PubMed
    1. Annu Rev Immunol. 1984;2:127-57 - PubMed

Publication types

Substances

LinkOut - more resources